MIRATAZ- mirtazapine ointment

Страна: США

мова: англійська

Джерело: NLM (National Library of Medicine)

Активний інгредієнт:

MIRTAZAPINE (UNII: A051Q2099Q) (MIRTAZAPINE - UNII:A051Q2099Q)

Доступна з:

Kindred Biosciences, Inc.

Адміністрація маршрут:

TOPICAL

Тип рецепту:

PRESCRIPTION

Терапевтичні свідчення:

Mirataz™ is contraindicated in cats with a known hypersensitivity to mirtazapine or to any of the excipients. Mirataz™ should not be given in combination, or within 14 days before or after treatment with a monoamine oxidase inhibitor (MAOI) [e.g. selegiline hydrochloride (L-deprenyl), amitraz], as there may be an increased risk of serotonin syndrome.

Огляд продуктів:

Mirataz™ is supplied in a 5 gram aluminum tube.

Статус Авторизація:

New Animal Drug Application

Характеристики продукта

MIRATAZ- MIRTAZAPINE OINTMENT
KINDRED BIOSCIENCES, INC.
----------
MIRATAZ™
(MIRTAZAPINE TRANSDERMAL OINTMENT)
Each 1 g of Mirataz™ contains 20 mg mirtazapine (2%). Each 5 g tube
contains 100mg (0.1 g) of
mirtazapine.
For topical application in cats only. Not for oral or ophthalmic use.
CAUTION:
Federal law (USA) restricts this drug to use by or on the order of a
licensed veterinarian.
DESCRIPTION:
Mirataz™ (mirtazapine transdermal ointment) is a white to off-white
ointment containing 2% (w/w) of
mirtazapine suitable for transdermal (topical) administration.
Mirataz™ contains the following inactive
ingredients: Polyethylene Glycol (PEG) 400, PEG 3350, Diethylene
Glycol Monoethyl Ether, PEG-8
Caprylic/Capric Glycerides, Oleyl Alcohol, Butylated Hydroxytoluene,
Dimethicone, and Dry Flo TS.
The structural formula of mirtazapine is:
Molecular Formula: C
H N MolecularWeight: 265.35
INDICATION:
Mirataz™ is indicated for the management of weight loss in cats.
DOSAGE AND ADMINISTRATION:
Administer topically by applying a 1.5-inch ribbon of ointment
(approximately 2 mg/cat) on the inner
pinna of the cat's ear once daily for 14 days (see Diagrams below).
Wear disposable gloves when applying Mirataz™. Dispose of used
gloves after each application.
Alternate the daily application of Mirataz™ between the left and
right inner pinna of the ears. Do not
administer into the external ear canal. If desired, the inner pinna of
the cat's ear may be cleaned by
wiping with a dry tissue or cloth immediately prior to the next
scheduled dose. If a dose is missed,
apply Mirataz™ the following day and resume daily dosing.
To demonstrate the method of administering the dose, the veterinarian
or trained personnel at the clinic
should apply the first dose in the presence of the owner.
17
19
3
This ruler measures 1.5 inches. Use this ruler to measure the 1.5 inch
ribbon of ointment to be applied.
CONTRAINDICATIONS:
Mirataz™ is contraindicated in cats with a known hypersensitivity to
mirtazapine or to any of the
excipients.
Mir